Citra Labs : A Biomet Biologics Company

ACD-A Anticoagulant Citrate Dextrose Solution, Solution A

ACD-A Anticoagulant Citrate Dextrose Solution, Solution A
  • ACD-A Anticoagulant Citrate Dextrose Solution, Solution A, USP (2.13% free citrate ion), is a sterile, non-pyrogenic solution. ACD-A is used as an anticoagulant in the extracorporeal blood processing with Autologous PRP Systems in production of Platelet-Rich Plasma (PRP).

Citrate-based anticoagulants prevent the coagulation of blood by virtue of the citrate ion's ability to chelate ionized calcium present in the blood to form a non-ionized calcium-citrate complex.

  • ACD-A is the only anticoagulant product approved by the United States Food & Drug Administration for the use in Autologous PRP Systems for the preparation of Platelet-Rich Plasma (PRP).

Important Safety Information

Indications

Anticoagulant Citrate Dextrose Solution, Solution A, U.S.P. (ACD-A) is intended for use as an anticoagulant in the extracorporeal blood processing with Autologous Platelet-Rich Plasma (PRP) Systems in production of PRP.

Warnings and Contraindications

ACD-A is not for direct intravenous infusion.

Side Effects

None known.